BioSpace News Archive

Surgalign Holdings, Inc. today announced that it has granted restricted stock unit awards to three employees.

Shineco, Inc. announced that on November 18, 2021, it entered into non-binding framework agreements (the “Framework Agreements”) with certain shareholders of Xiang Peng You Kang (Beijing) Technology Co., Ltd.

Healthcare + Expo Taiwan to Build an Ecosystem of Digital Transformation in Healthcare.

The global blood-brain barrier market size is expected to reach USD 7.40 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research.

The global next generation implants market is expected to reach a market size of USD 4.45 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research.

Development of technologically advanced peptide synthesizers and availability of various peptide synthesis reagents are driving market revenue growth.

SK Life Science, Inc. will present new post-hoc, retrospective analyses of the long-term safety and efficacy of its anti-seizure medication (ASM) XCOPRI® (cenobamate tablets) CV at the American Epilepsy Society (AES) Annual Meeting, held December 3-7, 2021 in Chicago, Illinois.

Psyence Group Inc. is pleased to announce that Psyence Chief Executive Officer, Neil Maresky, will be presenting at the virtual H.C. Wainwright 2nd Annual Psychedelics Conference on December 6th , 2021.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 11 newly-hired employees inducement options to purchase an aggregate of 84,000 shares of BioCryst common stock on November 30, 2021 as inducements material to each employee entering into employment with BioCryst.

Surface Oncology today announced that the company was named one of the Top Places to Work in Massachusetts in 2021 by the Boston Globe.